The Bio Report
Biopharma R&D Growing Stronger
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:30:36
- Mais informações
Informações:
Sinopse
Funding levels, drug launches, and R&D success rates all grew in 2023, according to a new report from the IQVIA Institute for Human Data Science. Global funding of biopharmaceutical research and development increased to $72 billion, up from $61 billion in 2022. M&A activity jumped to $140 billion from $78 billion during the same period. We spoke to Murray Aitken, executive director of the IQVIA Institute for Human Data Science, about its Global Trends in R&D 2024 report, what he’s watching, and why the new patent cliff for the industry will be less threatening than the last one.